Microbiome and Gut Dysbiosis

Area of Science:

• Microbiology
• Gastroenterology
• Immunology

Background:

• The gastrointestinal tract hosts trillions of microorganisms, forming the gut microbiome.
• This microbiome plays vital roles in digestion, metabolism, and immune system regulation.
• Host-microbial interactions are essential for maintaining homeostasis.

Purpose of the Study:

• To review recent discoveries linking gut microbiome dysbiosis to metabolic and inflammatory diseases.
• To explore potential prophylactic and therapeutic applications targeting the gut microbiome.

Main Methods:

• Review of current scientific literature on gut microbiome composition and function.
• Analysis of studies investigating the link between dysbiosis and various diseases.
• Examination of emerging therapeutic strategies for microbiome-related disorders.

Main Results:

• Gut dysbiosis is associated with inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), diabetes, obesity, cancer, and CNS disorders.
• Specific microbial communities are identified as potential targets for treating inflammatory and infectious diseases.
• Intestinal microbiota transplantation (IMT) is a viable treatment for IBD, especially recurrent Clostridium difficile infections.

Conclusions:

• Gut microbiome dysbiosis is implicated in a wide range of metabolic and inflammatory conditions.
• Therapeutic interventions such as fecal microbiota transplantation, phage therapy, probiotics, and prebiotics offer promising avenues for treatment.
• Targeting the gut microbiome holds significant potential for disease prevention and therapy.